| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2024 Q4 | Jan 9, 2025 | ClearBridge Investments Small Cap Growth Strategy | - | - | AZPN, BE, CERT, CHX, CWAN, FLR, FOUR, MOD, OSCR, PCVX, SGRY, SHLS, TGTX, VIAV, VRNS, WING, WIX, XMTR, XPO, ZETA | AI, growth, healthcare, industrials, M&A, Onshoring, small caps, technology | The unprecedented infrastructure buildout to support generative AI ambitions drove accelerating growth and expanding multiples across multiple sectors. This enthusiasm expanded from AI/chips to data center buildouts, HVAC equipment, service providers, and power solutions to support electricity demands of this generational product cycle. | MOD FLR CWAN TGTX OSCR BE |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Fund Letters | ClearBridge Investments Small Cap Growth Strategy | TG Therapeutics | Health Care | Biotechnology | Bull | NASDAQ | biotechnology, Briumvi, Chronic Disease, Commercial Stage, market share growth, multiple sclerosis, Pharmaceutical | View Pitch |
| Apr 1, 2026 | Seeking Alpha | Seeking Alpha | TG Therapeutics, Inc. | Biotechnology | Pharmaceuticals | Bull | NASDAQ Stock Market | biopharmaceutical, blockbuster drug, Briumvi, Buyback program, Clinical trials, direct-to-consumer marketing, ENHANCE trial, multiple sclerosis, non-dilutive capital, sales force expansion | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||